AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10824207 — intervention group
Group type: COMPARATOR
Intervention: No chest radiography
Number of subjects: 273
Study 8651143 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment for cocaine abuse
Number of subjects: 0
Study 8651143 — intervention group
Group type: EXPERIMENTAL
Intervention: Less educated patients who smoked or injected cocaine
Number of subjects: 0
Study 1514915 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenprocoumon (n = 66)
Number of subjects: 130
Study 1514915 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 64)
Number of subjects: 130
Study 6403933 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol (100 mg)
Number of subjects: 63
Study 6403933 — intervention group
Group type: COMPARATOR
Intervention: Morphine (15 mg)
Number of subjects: 63
Study 31402571 — intervention group
Group type: COMPARATOR
Intervention: Thin liquid (control)
Number of subjects: 120
Study 31402571 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener at 150 mPa s
Number of subjects: 120
Study 31402571 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener at 1400 mPa s
Number of subjects: 120
Study 31402571 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener (various viscosities)
Number of subjects: 120
Study 31402571 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthan gum-based thickener at ≥450 mPa s
Number of subjects: 120
Study 29489011 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐based instruction (CBI)
Number of subjects: 0
Study 29489011 — intervention group
Group type: COMPARATOR
Intervention: Behavioral Skills Training (BST)
Number of subjects: 0
Study 26945767 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional perioperative antibiotics plus vancomycin and gentamicin injection (once)
Number of subjects: 60
Study 26945767 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional perioperative antibiotics plus vancomycin and gentamicin injection (twice)
Number of subjects: 60
Study 26945767 — intervention group
Group type: COMPARATOR
Intervention: Conventional perioperative antibiotics only (Control group)
Number of subjects: 60
Study 24282083 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy (EIS)
Number of subjects: 9400
Study 24282083 — intervention group
Group type: COMPARATOR
Intervention: Selectively invasive strategy (SIS)
Number of subjects: 9400
Study 22863467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-syringe power injector
Number of subjects: 275
Study 22863467 — intervention group
Group type: COMPARATOR
Intervention: Syringeless power injector
Number of subjects: 275
Study 20224282 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 0
Study 20224282 — intervention group
Group type: COMPARATOR
Intervention: Non-LLA users
Number of subjects: 0
Study 18067630 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery
Number of subjects: 75
Study 18067630 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU)
Number of subjects: 75
Study 18067630 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Imiquimod (IMIQ)
Number of subjects: 75
Study 16385220 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of 4 different types of condoms
Number of subjects: 414
Study 16385220 — intervention group
Group type: COMPARATOR
Intervention: Standard clinic condom
Number of subjects: 414
Study 12785625 — intervention group
Group type: EXPERIMENTAL
Intervention: phone-message prompt
Number of subjects: 60
Study 12785625 — intervention group
Group type: EXPERIMENTAL
Intervention: phone-voice prompt
Number of subjects: 60
Study 12785625 — intervention group
Group type: COMPARATOR
Intervention: no prompt
Number of subjects: 60
Study 10491528 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oral conjugated equine estrogen (ERT)
Number of subjects: 130
Study 10491528 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (non-ERT)
Number of subjects: 130
Study 8686714 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (< 3 micrograms/kg/min)
Number of subjects: 256
Study 8686714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 1897377 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (acute, intravenous administration)
Number of subjects: 14
Study 6344699 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine (5 mg preservative-free morphine sulfate in 10 ml saline)
Number of subjects: 40
Study 6344699 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 40
Study 6344699 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 40
Study 31367877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) via gastroscopy
Number of subjects: 27
Study 31367877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) via colonoscopy
Number of subjects: 27
Study 31367877 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 27
Study 29503060 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrulline (CIT) supplementation
Number of subjects: 24
Study 29503060 — intervention group
Group type: COMPARATOR
Intervention: Non-essential amino acids (NEAA)
Number of subjects: 24
Study 28383434 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure group (12 mm Hg, HP group, n=26)
Number of subjects: 68
Study 28383434 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure group (8 mm Hg, LP group, n=20)
Number of subjects: 68
Study 28383434 — intervention group
Group type: COMPARATOR
Intervention: Open operation group (OP group, n=22)
Number of subjects: 68
Study 25416927 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus casei Shirota (LcS)
Number of subjects: 0
Study 24298897 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel-prednisone plus AT-101
Number of subjects: 1094
Study 24298897 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone plus sunitinib
Number of subjects: 1094
Study 24298897 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic progression
Number of subjects: 1094
Study 22862854 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia abutment
Number of subjects: 20
Study 22862854 — intervention group
Group type: COMPARATOR
Intervention: Titanium abutment
Number of subjects: 20
Study 19054831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-threshold micropulse diode laser photocoagulation (MPDL)
Number of subjects: 53
Study 19054831 — intervention group
Group type: COMPARATOR
Intervention: Conventional green laser photocoagulation (CGL)
Number of subjects: 53
Study 19054831 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MPDL and CGL
Number of subjects: 53
Study 17894033 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CPB)
Number of subjects: 15
Study 17894033 — intervention group
Group type: EXPERIMENTAL
Intervention: Xeno III
Number of subjects: 15
Study 17894033 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Unifil Bond (GC)
Number of subjects: 15
Study 17894033 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond XP (P & B)
Number of subjects: 15
Study 17894033 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop (APL)
Number of subjects: 15
Study 15646240 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated night shift (meals at 01:00/07:00 h and snack at 04:00 h)
Number of subjects: 8
Study 11740389 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg once daily
Number of subjects: 154
Study 11740389 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril 10 mg once daily
Number of subjects: 154
Study 9212759 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 21
Study 7959378 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive hemodynamic monitoring and treatment before operation (group A)
Number of subjects: 78
Study 7959378 — intervention group
Group type: COMPARATOR
Intervention: No invasive hemodynamic monitoring before operation (group B)
Number of subjects: 78
Study 3082645 — intervention group
Group type: EXPERIMENTAL
Intervention: h-GRF-44 2.5 micrograms
Number of subjects: 7
Study 3082645 — intervention group
Group type: EXPERIMENTAL
Intervention: h-GRF-44 5 micrograms
Number of subjects: 7
Study 3082645 — intervention group
Group type: EXPERIMENTAL
Intervention: h-GRF-44 10 micrograms
Number of subjects: 7
Study 3082645 — intervention group
Group type: EXPERIMENTAL
Intervention: h-GRF-44 20 micrograms
Number of subjects: 7
Study 3082645 — intervention group
Group type: EXPERIMENTAL
Intervention: h-GRF-44 40 micrograms
Number of subjects: 7
Study 3082645 — intervention group
Group type: EXPERIMENTAL
Intervention: h-GRF-44 80 micrograms
Number of subjects: 7
Study 3082645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 31132547 — intervention group
Group type: EXPERIMENTAL
Intervention: Group occupational therapy
Number of subjects: 70
Study 31132547 — intervention group
Group type: COMPARATOR
Intervention: Individual occupational therapy
Number of subjects: 70
Study 29282199 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-blotter A1C measurement
Number of subjects: 0
Study 29282199 — intervention group
Group type: COMPARATOR
Intervention: Lab-blotter A1C measurement
Number of subjects: 0
Study 29282199 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-blotter and Lab-blotter A1C measurements
Number of subjects: 0
Study 29282199 — intervention group
Group type: EXPERIMENTAL
Intervention: Home sampling preference
Number of subjects: 0
Study 27842539 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application designed to improve self-management of T2DM
Number of subjects: 0
Study 27842539 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 25391196 — intervention group
Group type: EXPERIMENTAL
Intervention: High kVp technique with multi-layer filter
Number of subjects: 132
Study 25391196 — intervention group
Group type: COMPARATOR
Intervention: Traditional copper filter
Number of subjects: 132
Study 23062020 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Meditation and Ear Acupressure (IMEA)
Number of subjects: 56
Study 23062020 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 56
Study 20673972 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 59
Study 20673972 — intervention group
Group type: COMPARATOR
Intervention: Placebo video
Number of subjects: 59
Study 18201352 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of calcipotriol or maxacalcitol ointment before phototherapy
Number of subjects: 6
Study 18201352 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of calcipotriol or maxacalcitol ointment after phototherapy
Number of subjects: 6
Study 18201352 — intervention group
Group type: COMPARATOR
Intervention: Phototherapy with PUVA or NB-UVB
Number of subjects: 6
Study 16533076 — intervention group
Group type: EXPERIMENTAL
Intervention: Text chat
Number of subjects: 22
Study 16533076 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone
Number of subjects: 22
Study 16533076 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher executive ability in AS participants
Number of subjects: 22
Study 16533076 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower executive ability in AS participants
Number of subjects: 22
Study 16533076 — intervention group
Group type: COMPARATOR
Intervention: Typically developing comparison group
Number of subjects: 22
Study 12830260 — intervention group
Group type: EXPERIMENTAL
Intervention: Prisoners in security cells
Number of subjects: 30
Study 12830260 — intervention group
Group type: EXPERIMENTAL
Intervention: Prisoners in security cells with previous contact with prison psychiatric service
Number of subjects: 30
Study 12830260 — intervention group
Group type: COMPARATOR
Intervention: Non-secluded inmates
Number of subjects: 30
Study 10926433 — intervention group
Group type: EXPERIMENTAL
Intervention: Compomer
Number of subjects: 45
Study 10926433 — intervention group
Group type: COMPARATOR
Intervention: Resin adhesive
Number of subjects: 45
Study 8761382 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus post-operative radiotherapy (SR)
Number of subjects: 308
Study 8761382 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 308
Study 8761382 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus post-operative radiotherapy (SR) in N2 group
Number of subjects: 308
Study 8761382 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S) in N2 group
Number of subjects: 308
Study 8761382 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus post-operative radiotherapy (SR) in N1 group
Number of subjects: 308
Study 8761382 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S) in N1 group
Number of subjects: 308
Study 1330083 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucomannan plus rifaximin 400 mg bid for 7 days each month
Number of subjects: 217
Study 1330083 — intervention group
Group type: COMPARATOR
Intervention: Glucomannan only
Number of subjects: 217
Study 6788433 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 units of factor VIII per kg
Number of subjects: 339
Study 6788433 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 units of factor VIII per kg
Number of subjects: 339
Study 6788433 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 units of factor VIII per kg
Number of subjects: 339
Study 6788433 — intervention group
Group type: COMPARATOR
Intervention: Low doses of factor VIII (7 or 14 units per kg)
Number of subjects: 339
Study 30808949 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed casein formula containing the probiotic L.rhamnosus GG (EHCF + LGG)
Number of subjects: 20
Study 30808949 — intervention group
Group type: COMPARATOR
Intervention: Soy formula (SF)
Number of subjects: 20
Study 28181192 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-pill triple combination of perindopril 5 mg/indapamide 1.25 mg/amlodipine 5 mg (Per/Ind/Aml)
Number of subjects: 148
Study 28181192 — intervention group
Group type: COMPARATOR
Intervention: Dual-pill combination of perindopril 5 mg/indapamide 1.25 mg + amlodipine 5 mg (Per/Ind + Aml)
Number of subjects: 148
Study 25554014 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 401
Study 25554014 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 401
Study 23190017 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib (R788)
Number of subjects: 3
Study 23190017 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib suspension
Number of subjects: 3
Study 23190017 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib tablet
Number of subjects: 3
Study 23190017 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib with food
Number of subjects: 3
Study 23190017 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ascending dose of R406
Number of subjects: 3
Study 20526624 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Assisted Thyroidectomy (VAT)
Number of subjects: 112
Study 20526624 — intervention group
Group type: COMPARATOR
Intervention: Conventional Thyroidectomy (CT)
Number of subjects: 112
Study 19713982 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0
Study 19713982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17278225 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid proctoscope
Number of subjects: 41
Study 17278225 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible endoscope
Number of subjects: 41
Study 16527796 — intervention group
Group type: EXPERIMENTAL
Intervention: NTI under curve-tipped suction catheter (CTSC) guidance (G[+] group)
Number of subjects: 131
Study 16527796 — intervention group
Group type: COMPARATOR
Intervention: NTI without CTSC guidance (G[‐] group)
Number of subjects: 131
Study 16527796 — intervention group
Group type: EXPERIMENTAL
Intervention: NTI under CTSC guidance (G[+] group)
Number of subjects: 131
Study 12743003 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistently elevated immunocomplex (IC)-bound and/or serum IgA antibodies to C pneumoniae
Number of subjects: 4081
Study 12743003 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IgA antibodies to hHsp60
Number of subjects: 4081
Study 12743003 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistently elevated CRP and C pneumoniae IC/IgA antibodies together
Number of subjects: 4081
Study 12743003 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP and hHsp60 IgA antibodies together
Number of subjects: 4081
Study 10484540 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 12 weeks
Number of subjects: 17
Study 10484540 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 17
Study 8940863 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 0
Study 8940863 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care after PEG
Number of subjects: 0
Study 8940863 — intervention group
Group type: COMPARATOR
Intervention: Hospital care after PEG
Number of subjects: 0
Study 8940863 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rates
Number of subjects: 0
Study 8940863 — intervention group
Group type: EXPERIMENTAL
Intervention: Care at home after PEG
Number of subjects: 0
Study 8940863 — intervention group
Group type: EXPERIMENTAL
Intervention: Complication development rate
Number of subjects: 0
Study 8940863 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life improvement
Number of subjects: 0
Study 1950351 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest in hospital from 24 weeks gestation until delivery
Number of subjects: 19
Study 1950351 — intervention group
Group type: COMPARATOR
Intervention: Conventional outpatient management
Number of subjects: 19
Study 7020093 — intervention group
Group type: EXPERIMENTAL
Intervention: Niclofolan 2 mg/kg
Number of subjects: 60
Study 7020093 — intervention group
Group type: EXPERIMENTAL
Intervention: Niclofolan 3 mg/kg
Number of subjects: 60
Study 7020093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31848678 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline unshifted adipofascial turn‐over flap
Number of subjects: 192
Study 31848678 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline shifted adipofascial turn‐over flap
Number of subjects: 192
Study 31848678 — intervention group
Group type: EXPERIMENTAL
Intervention: Karydakis flap
Number of subjects: 192
Study 30135778 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert evaluation
Number of subjects: 439
Study 30135778 — intervention group
Group type: EXPERIMENTAL
Intervention: User evaluation
Number of subjects: 439
Study 30135778 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral text
Number of subjects: 439
Study 30135778 — intervention group
Group type: COMPARATOR
Intervention: Control (no information)
Number of subjects: 439
Study 28392237 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular point-of-care testing (POCT) for respiratory viruses
Number of subjects: 720
Study 28392237 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (Control)
Number of subjects: 720
Study 26017321 — intervention group
Group type: EXPERIMENTAL
Intervention: Substituting whole grain brown rice for polished (refined) white rice
Number of subjects: 0
Study 26017321 — intervention group
Group type: COMPARATOR
Intervention: Polished (refined) white rice
Number of subjects: 0
Study 23823347 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemomechanical method (papain gel)
Number of subjects: 60
Study 23823347 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods using low speed drills
Number of subjects: 60
Study 20506993 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-optimized LASIK (ALLEGRETTO)
Number of subjects: 51
Study 20506993 — intervention group
Group type: COMPARATOR
Intervention: Conventional LASIK (LADAR4000)
Number of subjects: 51
Study 18067499 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg/kg ev bolus followed by 1 mg/kg/hour perfusion)
Number of subjects: 95
Study 18067499 — intervention group
Group type: COMPARATOR
Intervention: Control (saline matching the protocol)
Number of subjects: 95
Study 18067499 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study 15694946 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day for 4 weeks)
Number of subjects: 38
Study 15694946 — intervention group
Group type: COMPARATOR
Intervention: Control (no statin)
Number of subjects: 38
Study 12609944 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone review
Number of subjects: 278
Study 12609944 — intervention group
Group type: COMPARATOR
Intervention: Face to face consultation
Number of subjects: 278
Study 10533554 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 152
Study 10533554 — intervention group
Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 152
Study 8708970 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic beta-blockers
Number of subjects: 29
Study 8708970 — intervention group
Group type: COMPARATOR
Intervention: Non-medicated group
Number of subjects: 29
Study 1750779 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence group
Number of subjects: 54
Study 1750779 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 7062419 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy
Number of subjects: 40
Study 7062419 — intervention group
Group type: COMPARATOR
Intervention: Chloroethyl-cyclohexy-nitrosourea
Number of subjects: 40
Study 31259673 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (90 μg)
Number of subjects: 46
Study 31259673 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (180 μg)
Number of subjects: 46
Study 31259673 — intervention group
Group type: EXPERIMENTAL
Intervention: FPS (100/50 μg)
Number of subjects: 46
Study 31259673 — intervention group
Group type: EXPERIMENTAL
Intervention: FPS (200/100 μg)
Number of subjects: 46
Study 31259673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46